Status and phase
Conditions
Treatments
About
With regard to Cerebral Venous Thrombosis (CVT) importance as a life threatening disease, specific care is necessary, Known anti-coagulants have limitations.Vitamin K antagonists such as Warfarin, require laboratory monitoring and exact administration starting and maintenance dose. although Rivaroxaban(selective and direct Xa factor antagonist ) has no monitoring and no drug interaction. This study aim to focus on efficacy of Warfarin versus Rivaroxaban.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
IInclusion Criteria:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Central trial contact
Mohammad Javad Farajpour Khanaposhtani, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal